LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Siemens Healthineers Demonstrates Power of Data with Atellica Diagnostics IT Solutions

By LabMedica International staff writers
Posted on 05 Aug 2019
Print article
Image: The Atellica Diagnostics IT portfolio is helping labs manage increasing workloads, staffing challenges, and decreasing budgets with innovative data-driven solutions (Photo courtesy of Siemens Healthineers).
Image: The Atellica Diagnostics IT portfolio is helping labs manage increasing workloads, staffing challenges, and decreasing budgets with innovative data-driven solutions (Photo courtesy of Siemens Healthineers).
Siemens Healthineers (Erlangen, Germany) demonstrated the power of leveraging data to unlock a laboratory’s full potential by showcasing its Atellica Diagnostics IT portfolio at the 71st AACC Annual Scientific Meeting & Clinical Lab Expo. At AACC 2019, the company featured its innovative IT solutions to combat the laboratory’s staffing challenges, limited budgets, and the increasing complexity in sample management and testing.

The Siemens Healthineers Atellica Diagnostics IT portfolio enables laboratories to unlock their full potential by leveraging data to optimize workflows. With easy-to-navigate user interfaces and centralized management of operations, the robust software solution enhances visibility into valuable business analytics that unify sample, process, result, and inventory data. These features have enabled laboratories to achieve a 93% reduction in testing errors, an 85% increase in patient and staff satisfaction, and an 88% achievement rate for 30-minute STAT turnaround.

The Atellica portfolio pipeline includes the Atellica Asa Application, a tablet-based virtual assistant designed to simplify and organize operator interactions with the instruments. The goal of the Atellica Asa Application is to draw staff attention to a single interface with only the most common, yet critical, procedures needed to complete daily system operations. The tile-based software is designed to organize operator tasks by workflow and to reduce the number of screens used to complete a single task.

In addition to demonstrations of the Atellica Asa virtual assistant, attendees learned more about LifeNet, an online program that helps labs increase system utilization by providing a centralized platform to schedule system maintenance and view service history of connected Siemens Healthineers systems. Attendees also explored the artificial intelligence-driven Guardian Program, which can help to predict certain system failures up to 21 days before they happen. By monitoring more than 80 critical components in real time, the Guardian Program can continuously detect potential issues and schedule repairs at a time that will not affect turnaround time, maintaining workflow during peak hours. Visitors to the Siemens Healthineers booth also experienced their own virtual reality journey through a simulated hospital environment to visualize in vitro testing and workflow possibilities based upon tailored needs.

Additionally, Siemens Healthineers unveiled its newest technology for point-of-care testing—the RAPIDPoint 500e Blood Gas System—for product demonstration at the event.

“Point-of-care testing enables clinicians to deliver the right test in the right setting for their patients at the right time,” said Christoph Pedain, PhD, Head of Point-of-Care Diagnostics, Siemens Healthineers.

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Complement 3 (C3) Test
GPP-100 C3 Kit
New
Gold Member
Plasma Control
Plasma Control Level 1

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: The AI predictive model identifies the most potent cancer killing immune cells for use in immunotherapies (Photo courtesy of Shutterstock)

AI Predicts Tumor-Killing Cells with High Accuracy

Cellular immunotherapy involves extracting immune cells from a patient's tumor, potentially enhancing their cancer-fighting capabilities through engineering, and then expanding and reintroducing them into the body.... Read more

Microbiology

view channel
Image: The T-SPOT.TB test is now paired with the Auto-Pure 2400 liquid handling platform for accurate TB testing (Photo courtesy of Shutterstock)

Integrated Solution Ushers New Era of Automated Tuberculosis Testing

Tuberculosis (TB) is responsible for 1.3 million deaths every year, positioning it as one of the top killers globally due to a single infectious agent. In 2022, around 10.6 million people were diagnosed... Read more